These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8137477)

  • 1. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.
    Suto T; Fukuda S; Moriya N; Watanabe Y; Sasaki D; Yoshida Y; Sakata Y
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S145-8. PubMed ID: 8137477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
    Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
    Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
    Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S; Tanaka K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma.
    Lencioni R; Vignali C; Caramella D; Cioni R; Mazzeo S; Bartolozzi C
    Cardiovasc Intervent Radiol; 1994; 17(2):70-5. PubMed ID: 8013026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization.
    Tanaka K; Nakamura S; Numata K; Okazaki H; Endo O; Inoue S; Takamura Y; Sugiyama M; Ohaki Y
    Radiology; 1992 Nov; 185(2):457-60. PubMed ID: 1329143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
    Ishii H; Okada S; Sato T; Nose H; Okusaka T; Yoshimori M; Takayasu K; Takayama T; Kosuge T; Yamasaki S
    Hepatogastroenterology; 1996; 43(9):644-50. PubMed ID: 8799409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study.
    Ryu M; Shimamura Y; Kinoshita T; Konishi M; Kawano N; Iwasaki M; Furuse J; Yoshino M; Moriyama N; Sugita M
    Jpn J Clin Oncol; 1997 Aug; 27(4):251-7. PubMed ID: 9379514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
    Motohara T; Ozawa Z; Morita S
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma.
    Kato T; Saito Y; Niwa M; Ishiguro J; Ogoshi K
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S115-8. PubMed ID: 8137469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of 116 patients with hepatocellular carcinoma.
    Onodera H; Ukai K; Nakano N; Takeda T; Suzuki H; Okata T; Motojima T; Kuwashima I; Ujiie S; Shoji T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S103-8. PubMed ID: 8137466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapy complementary to transcatheter arterial embolization for hepatocellular carcinoma.
    Yamada R; Nakamura K; Nishida N; Matsuoka T; Yamada K; Tanaka K; Terada M; Sato M
    World J Surg; 2001 Mar; 25(3):381-5; discussion 385-6. PubMed ID: 11343199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.